Literature DB >> 6889902

Pharmacological evidence for the subclassification of central dopamine receptors in the rat.

A J Gower, A S Marriott.   

Abstract

1 The relative potencies of dopamine receptor agonists in causing stereotypy in rats when injected into the olfactory tubercles, and contralateral rotation when injected unilaterally into the caudate nucleus of rats with lesions of the nigro-striatal dopamine pathway, were determined. The actions of some agonists in eliciting these responses following peripheral injection, and the relative potencies of dopamine receptor antagonists in inhibiting them were also determined. 2 Dopamine, apomorphine and 2-amino-5,6 and 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (A-5, 6 DTN, A-6, 7 DTN) and N,N dipropyl A-5, 6DTN induced both responses. In contrast, 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine HCl (SK & F 38393) whether injected intracerebrally or peripherally, induced contralateral rotation but not stereotypy. 3 Contralateral rotation and stereotypy induced by apomorphine or N,N dipropyl A-5, 6 DTN were inhibited by haloperidol, pimozide and fluphenazine but these drugs failed to inhibit rotation induced by SK & F 38393. Clozapine inhibited rotation induced by SK & F 38393, apomorphine or N,N dipropyl A-5,6 DTN but failed to inhibit stereotypy. Loxapine was more potent in inhibiting stereotypy than rotation,, whereas clothiapine inhibited rotation and stereotypy at similar doses irrespective of the agonist used to elicit the response. 4 Contralateral rotation induced by SK & F 38393 was not inhibited by yohimbine, prazosin, atropine, methysergide, mepyramine or propranolol. 5 The results provide evidence that contralateral rotation induced by dopamine receptor agonists is mediated by two different classes of dopamine receptors and that these receptors differ from those mediating the stereotypy response. 6 The receptors mediating these responses appear classifiable in terms of their sensitivity to the agonist actions of SK & F 38393 or apomorphine respectively. SK & F 38393-sensitive receptors are susceptible to blockade by clozapine but are not blocked by haloperidol, pimozide or fluphenazine. Apomorphine-sensitive receptors are susceptible to blockade by haloperidol, pimozide and fluphenazine but appear divisible into two sub-classes depending on whether or not they are blocked by clozapine and on their sensitivity to blockade by loxapine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6889902      PMCID: PMC2044655          DOI: 10.1111/j.1476-5381.1982.tb09285.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  Apomorphine as an antagonist of the dopamine response from the nucleus accumbens.

Authors:  B Costall; R J Naylor
Journal:  J Pharm Pharmacol       Date:  1976-07       Impact factor: 3.765

2.  Differences in the nature of the stereotyped behaviour induced by aporphine derivatives in the rat and in their actions in extrapyramidal and mesolimbic brain areas.

Authors:  B Costall; R J Naylor; J L Neumeyer
Journal:  Eur J Pharmacol       Date:  1975-03       Impact factor: 4.432

3.  Aporphines. 15. Action of aporphine alkaloids on dopaminergic mechanisms in rat brain.

Authors:  R J Miller; P H Kelly; J L Neumeyer
Journal:  Eur J Pharmacol       Date:  1976-01       Impact factor: 4.432

4.  Specific asymmetric behavior induced by the direct chemical stimulation of neostriatal dopaminergic mechanisms.

Authors:  B Costall; R J Naylor
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

5.  Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse.

Authors:  S Irwin
Journal:  Psychopharmacologia       Date:  1968-09-20

6.  Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

Authors:  U Ungerstedt; G W Arbuthnott
Journal:  Brain Res       Date:  1970-12-18       Impact factor: 3.252

7.  Localization of dopamine-sensitive adenylate cyclase within the rat olfactory tubercle.

Authors:  N R Krieger
Journal:  Brain Res       Date:  1980-02-10       Impact factor: 3.252

8.  Cerebral dopamine agonist properties of some 2-aminotetralin derivatives after peripheral and intracerebral administration.

Authors:  J G Cannon; T Lee; H D Goldman
Journal:  J Med Chem       Date:  1977-09       Impact factor: 7.446

9.  The pharmacology of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine (clozapine).

Authors:  G Stille; H Lauener; E Eichenberger
Journal:  Farmaco Prat       Date:  1971-10

10.  The central effects of a novel dopamine agonist.

Authors:  P E Setler; H M Sarau; C L Zirkle; H L Saunders
Journal:  Eur J Pharmacol       Date:  1978-08-15       Impact factor: 4.432

View more
  12 in total

1.  Place conditioning with dopamine D1 and D2 agonists injected peripherally or into nucleus accumbens.

Authors:  N M White; M G Packard; N Hiroi
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  The pharmacological characterisation of pilocarpine-induced purposeless chewing behaviour in the rat.

Authors:  B R Stewart; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

3.  Neurobehavioral development of CD-1 mice after combined gestational and postnatal exposure to ozone.

Authors:  G Dell'Omo; M Fiore; S Petruzzi; E Alleva; G Bignami
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

4.  Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors.

Authors:  A Butler; J M Hill; S J Ireland; C C Jordan; M B Tyers
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

5.  Heterogeneity of D2 dopamine receptors in different brain regions.

Authors:  M N Leonard; C A Macey; P G Strange
Journal:  Biochem J       Date:  1987-12-01       Impact factor: 3.857

6.  Dopamine D1 and D2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine.

Authors:  P M Callahan; J B Appel; K A Cunningham
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

7.  Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats.

Authors:  J Arnt; J Hyttel
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

8.  Failure of SKF 38393-A to relieve parkinsonian symptoms induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset.

Authors:  S P Close; A S Marriott; S Pay
Journal:  Br J Pharmacol       Date:  1985-06       Impact factor: 8.739

9.  Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primate.

Authors:  K K Gnanalingham; A J Hunter; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

10.  Stimulation of D1- or D2-receptors in drug-naive rats with different degrees of unilateral nigro-striatal dopamine lesions.

Authors:  J Fornaguera; J P Huston; R J Carey; R K Schwarting
Journal:  Psychopharmacology (Berl)       Date:  1995-05       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.